WASHINGTON — The deal was not announced from a major defense contractor’s gleaming headquarters. It came from a Salt Lake City company with $7.8 million in annual revenue announcing that it would manufacture Israeli-designed suicide drones for the United States military — exclusively.
Palladyne AI Corp. (Nasdaq: PDYN), a mid-tier American defense technology firm, announced Monday a strategic partnership with Israel Aerospace Industries under which Palladyne will acquire exclusive production and marketing rights for IAI’s HARPY, HAROP, and Mini HARPY loitering munition systems, adapting them for US operational requirements and manufacturing components and subsystems domestically. The target customer is the US Department of War.
The announcement marks the first time Israeli-developed loitering munitions — weapons that loiter over a battlefield and then self-detonate on a designated target — will be manufactured on American soil under an exclusive domestic licensing arrangement with an American company. IAI will provide engineering support and key subsystems; Palladyne will handle the rest.
What Palladyne is acquiring is a proven combat lineage. IAI’s Harpy family traces its origins to the late 1980s, when the company developed an autonomous anti-radiation weapon designed to circle enemy airspace and destroy radar systems on contact. The HAROP, a derivative, adds electro-optical sensors that allow operators to surveil a target area for hours before committing to a strike. The Pentagon has been accelerating its acquisition of AI-enabled autonomous weapons across the board, and the Harpy family fits that priority with decades of operational validation behind it.
Azerbaijan used HAROP drones against Armenian armor and radar installations during the 2020 Nagorno-Karabakh war, in what defence analysts described as the most significant operational debut for loitering munitions in a conventional conflict. The systems performed against hardened air defense infrastructure — exactly the scenario for which the US military is planning in any future confrontation with a peer or near-peer adversary.
Palladyne’s CEO Ben Wolff has described the company’s ambition as becoming a “mid-tier prime” — the kind of agile, integrated defense contractor that the Pentagon has been actively seeking to cultivate as an alternative to the traditional slow-moving giants. Since November 2025, Palladyne has acquired GuideTech, a Tucson-based avionics firm, and two precision manufacturing companies, building out what it calls an “autonomy-to-manufacturing stack.” The IAI partnership slots the Israeli systems directly into that stack.
The HARPY NG carries an anti-radiation seeker designed to locate and destroy adversary radar emitters autonomously. The HAROP adds a day-and-night electro-optical seeker that allows an operator to scan, identify, and attack stationary or moving targets at a range of up to 200 kilometers. The Mini HARPY is, by IAI’s account, the only loitering munition in the world carrying a triple seeker — electro-optical day, electro-optical night, and anti-radiation — in a compact airframe weighing 41 kilograms.
The question the announcement leaves unanswered is financial scale. Palladyne has not disclosed the value of the licensing arrangement, the target contract size with the Department of War, or the timeline for domestic manufacturing to reach operational readiness. The company guided full-year 2026 revenue of $24 million to $27 million before this deal was announced — figures that suggest the IAI partnership, if it generates material Pentagon contracts, would fundamentally transform the company’s financial profile. The Iran conflict exposed significant gaps in US air dominance capabilities that loitering munitions are positioned to address at lower cost per effect than conventional strike aircraft.
For Israel Aerospace Industries, the arrangement extends the Harpy family’s global footprint into the one market it had not formally penetrated: the US armed forces. Defense News has tracked IAI signing loitering munition contracts worth more than $145 million with undisclosed NATO-member customers in late 2023 alone. The US market, with its procurement scale, would represent the most significant expansion of that footprint in the system’s history.
The partnership also carries a geopolitical dimension that neither company addressed in Monday’s announcement. The HARPY was the subject of a significant US-Israel diplomatic dispute in 2004, when Washington demanded that Jerusalem seize Chinese-held Harpys being returned to Israel for upgrades, over concerns they could threaten American and Taiwanese forces in any future Taiwan conflict. Israel ultimately complied, returning the systems to China without upgrading them. That episode underscored how sensitive the Harpy family’s proliferation has always been inside the US national security establishment — which makes an exclusive US domestic production deal a notably different posture. The broader US-Israel defense relationship has grown more entangled throughout the Iran conflict, and this partnership reflects that trajectory.
What Palladyne has committed to is adaptation, not merely assembly. The company says it will modify the systems to meet US operational requirements — a process that in practice typically means integrating American-standard communications architecture, encryption, and datalink protocols. Whether the domestically produced versions will carry the same core Israeli subsystems or gradually migrate toward a fully American supply chain is not yet clear.
IAI president and chief executive Boaz Levy has previously described loitering munitions as having “proven critical to achieving operational success on the battlefield worldwide.” What he has not said is whether the Pentagon agrees — and whether the Department of War will actually sign procurement contracts with a company that generated $5.2 million in total revenue last year to supply a class of weapons it has never before formally acquired in this configuration. That question is the one this announcement cannot yet answer.
